Jemila Venner-Walcott

Jemila Venner-Walcott

Clinical Reviewer, Center for Biologics Evaluation and Research (CBER)

Role
Clinical Reviewer at FDA
Location
Washington, DC, US
LinkedIn followers
500 followers

About Jemila Venner-Walcott

Board-Certified Internal Medicine Physician and Regulatory Professional with unique expertise spanning high-acuity clinical care, medical research, and FDA regulatory review and strategy. As a Clinical Reviewer at the FDA/CBER, I provide critical evaluation and strategic guidance on the benefit-risk profile and clinical trial design of complex Cell, Tissue, and Gene Therapies, Medical Devices, and Combination Products for innovative Clinical Development Programs throughout the product lifecycle. I strive to accelerate innovative therapies and address global unmet needs.

Experience

  1. Clinical Reviewer

    FDA

    Nov 2023 — Present · Silver Spring, MD, US

    General Medicine BranchDivision of Clinical Evaluation General MedicineOffice of Clinical EvaluationOffice of Therapeutic Products

Education

  • The University of the West Indies, Mona

    Bachelor of Medicine, Bachelor of Surgery - MBBS

  • SUNY Downstate Medical Center

    Doctor of Medicine - MD, Internal Medicine Residency Program

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jemila Venner-Walcott — Clinical Reviewer at FDA in Washington, DC, US | Unifers